Streetbeat News

Stock Prices

TER

Northland Capital Markets analyst Gus Richard has upgraded Teradyne (NASDAQ:TER) from Market Perform to Outperform and set a price target of $126.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 11:39 am

INZY

Inozyme Pharma, Inc. (NASDAQ:INZY) has announced positive interim safety, pharmacokinetic (PK), pharmacodynamic (PD) and exploratory efficacy data from its ongoing Phase 1/2 clinical trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE, pseudoxanthoma elasticum).

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 11:37 am

SLNO

Soleno Therapeutics, Inc. (NASDAQ:SLNO) announced positive top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline) Extended-Release tablets for the treatment of Prader-Willi syndrome (PWS).

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 11:35 am

AAPL

META

Meta Platforms Inc.'s Quest 3 is set to compete with Apple Inc.'s Vision Pro. The Quest 3 will debut at the Meta Connect event on Sept. 27 and is rumored to hit the shelves on Oct. 10. The base model with 128GB of storage is priced at $499, with a higher-tier model priced at $649. The Quest 3 is expected to be equipped with the new Qualcomm Snapdragon XR2 Gen 2 chipset and 8 GB of RAM. In comparison, Apple’s Vision Pro has a hefty price tag of $3499 and will be available in early 2024.

Portfolio Pulse from Ananya Gairola

September 26, 2023 | 11:34 am

PLRX

Pliant Therapeutics, Inc. (NASDAQ:PLRX) announced positive data from a Phase 2a clinical trial of bexotegrast in patients with primary sclerosing cholangitis and suspected moderate to severe liver fibrosis. The trial met its primary and secondary endpoints, showing that bexotegrast was well tolerated and its plasma concentrations increased with dose. The drug also showed statistically significant differences in reducing liver fibrosis markers at the 160 mg dose relative to placebo at Week 12. Interim data from the high-dose 320 mg cohort is expected in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 11:33 am

BABA

FXI

KWEB

PDD

Alibaba Group Holding Limited (NYSE:BABA) plans to spin off Cainiao Smart Logistics Network Limited with a separate listing on the Hong Kong Stock Exchange, while retaining majority shareholding. This comes amid concerns over China's property sector, affecting Alibaba's stock and broader indexes like iShares China Large-Cap ETF (NYSE:FXI) and KraneShares Trust KraneShares CSI China Internet ETF (NYSE:KWEB). The global e-commerce sector is shifting towards discount retailing due to China's economic issues and inflation in the U.S. and Europe. Despite growth reported by Alibaba and JD.com Inc (NASDAQ:JD), PDD Holdings Inc (NASDAQ:PDD) reported a 66% YoY revenue increase, outperforming both.

Portfolio Pulse from Anusuya Lahiri

September 26, 2023 | 11:28 am

BABA

QQQ

SPY

TSLA

Stocks are set for a lower opening on Tuesday due to concerns about potential future rate hikes hinted by Minneapolis Federal Reserve President Neel Kashkari and weakness in global markets. Despite this, fund manager Louis Navellier expects a bullish end to the year, with the earnings environment improving and inflation excluding energy continuing to ebb. In premarket trading, the SPDR S&P 500 ETF Trust (NYSE:SPY) and the Invesco QQQ ETF (NASDAQ:QQQ) fell. Tesla, Inc. (NASDAQ:TSLA) also fell in premarket trading due to weak China weekly insurance registration data. Alibaba Group Holding Ltd. (NYSE:BABA) announced plans to spin off its Cainiao logistics unit in a Hong Kong IPO.

Portfolio Pulse from Shanthi Rexaline

September 26, 2023 | 11:23 am

SBRA

Hersha Hospitality Trust (HT) and Sabra Health Care REIT (SBRA) are identified as overbought stocks in the real estate sector, indicating potential short-term investment opportunities. HT recently announced a merger with KSL Capital Partners, while SBRA reported weaker-than-expected Q2 sales.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 11:12 am

ASHR

GLD

SPY

On Monday, US stock markets gained, breaking a four-day losing streak, with the S&P 500, Dow Jones, and Nasdaq all seeing increases. However, Asian markets, including Japan's Nikkei 225, Australia's S&P/ASX 200, China's Shanghai Composite, and Hong Kong's Hang Seng Index, all declined. European markets also opened lower. Commodities such as Crude Oil, Natural Gas, Gold, Silver, and Copper all saw decreases. US futures were down, and the U.S. Dollar Index was slightly down.

Portfolio Pulse from Akanksha Bakshi

September 26, 2023 | 11:07 am

OMGA

Omega Therapeutics, Inc. (NASDAQ:OMGA) announced preliminary data from its ongoing Phase 1/2 MYCHELANGELO I study evaluating OTX-2002 in patients with hepatocellular carcinoma and other solid tumors. The data shows encouraging safety, tolerability, and pharmacokinetic results. OTX-2002, the company's lead development candidate, is designed to downregulate MYC, a master oncogene implicated in more than 50% of all cancers and approximately 70% of HCC cases.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 11:03 am